🎗️ OncologyInjection (IV)
Lunsumio
Mosunetuzumab
CD20-CD3 bispecific T-cell engager for relapsed/refractory follicular lymphoma.
Form
Injection (IV)
Uses
1
Side effects
6
Category
Oncology
01
What is Lunsumio used for?
- Relapsed/refractory follicular lymphoma
02
Mosunetuzumab side effects
Common side effects of Mosunetuzumab include:
Cytokine release syndrome
Fever
Fatigue
Rash
Nausea
Infections
CommonModerateLess common
03
Mosunetuzumab warnings & precautions
- Black box: CRS and neurologic toxicity
- REMS program
- Serious infections
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Lunsumio in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.